Apple devices are fueling a huge new health study. This Boston doctor expects big breakthroughs.
Apple opened a massive new health study last week that will track data from hundreds of thousands of iPhone owners who volunteer to participate. The goal is to uncover previously unseen connections ...
STAT20h
Biogen partners with Stoke Therapeutics to sell severe epilepsy drug
From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...
Boston Scientific (BSX) Receives a Buy from Argus Research
Argus Research analyst David Toung maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 14. The company’s shares ...
Boston Scientific price target raised to $130 from $105 at Argus
Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...
MassDevice1d
Boston Scientific wins CE mark for Farapulse Nav mapping tech
Boston Scientific announced won CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview software.
GlobalData on MSN1d
Boston Scientific bags CE marking for Farapulse catheter and software
The tools ideate on Boston Scientific’s Farapulse PFA system, which contributed towards a 172% uptick in the company’s Q4 ...